Navigation Links
Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
Date:11/15/2011

CAMBRIDGE, Mass., Nov. 15, 2011 /PRNewswire/ -- Dr. Alice Jacobs, CEO of IntelligentMDx (IMDx), was named Best Entrepreneur for a non-service business of up to 100 employees in the eighth annual Stevie® Awards for Women in Business this past weekend.  The Stevie Awards for Women in Business honor women executives, entrepreneurs, and the companies they run – worldwide.  The awards are one of four Stevie Awards programs, which have been hailed as the world's premier business awards.

Dr. Jacobs' entrepreneurial spirit has fueled her passion for finding innovative solutions in healthcare. IMDx was founded out of what she believed was an underserved need in the industry: rapid and effective diagnostics to shrink the turnaround time between a patient presenting with an illness and a prescribed targeted treatment. Her first focus has been on healthcare-associated infections. By creating a company that offers inventive and rapid solutions to healthcare issues, Dr. Jacobs is fulfilling her goal of empowering physicians to make early, intelligent choices regarding patient treatment.

In 2011, IMDx has doubled in size, creating high technology jobs for top talent in the intellectual property, bioinformatics, research and development, project management, and manufacturing fields. Dr. Jacobs personally interviews each candidate to ensure synergy between her team members in order to facilitate the rapid and accurate development of diagnostics, which is the mission of IMDx.

"The broad range of expertise we have here at IMDx is what allows us to rapidly develop innovative diagnostics. It is inspiring to watch IMDx continue to grow and make a worldwide impact on the healthcare industry," says Dr. Jacobs. "It is an honor to be recognized as a Stevie Award Winner."

To date, IMDx has released two CE-marked diagnostic kits, which are being distributed globally by Abbott, targeting two of the most threatening healthcare-associated infections, Clostridium difficile, and vancomycin-resistant enterococci. The IMDx pipeline includes a range of infectious disease assays, a subset of which are currently being distributed globally by Abbott, as well as additional assays targeting oncology, human genetics and companion diagnostics. IMDx's platform-agnostic approach and bioinformatics-driven assay accelerator technology allow the company to play an important role in commercializing a breadth of new products.

More than 1,300 entries – a record for the Stevie Awards – were submitted this year for consideration in 75 categories, including Best Executive, Best Entrepreneur, Best New Company, and Communications Campaign of the Year. Finalists in the competition were chosen by business professionals worldwide during preliminary judging.  Members of six final judging committees selected Stevie Award winners from among the Finalists during final judging.  More than 200 professionals worldwide participated in the judging process this year.

"Women entrepreneurs and executives continue to innovate, excel, and impress," said Michael Gallagher, president of the Stevie Awards.  "Regardless of general economic conditions, the achievements of women-owned and -run organizations around the world remain high, and are reflected in this year's honorees."

Details about the Stevie Awards for Women in Business and the list of honorees are available at www.stevieawards.com/women.  

About IMDx

Based in Cambridge, MA, IMDx (www.IntelligentMDx.com) is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular solutions that are clinically impactful and competitively differentiated for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics. IMDx's expertise spans evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology. These capabilities are harnessed by IMDx's proprietary bioinformatics and product development processes allowing for the rapid design and development of tests to meet clinical needs.

About the Stevie Awards

Stevie Awards are conferred in four programs: The American Business Awards, The International Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service.  Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide.  Learn more about the Stevie Awards at www.stevieawards.com.

Sponsors and supporters of the 8th annual Stevie Awards for Women in Business include the Business TalkRadio Network, Coloredge, Infogroup, KeyBank | Key4Women, Melilea International Group of Companies, SDL, and Smart Reader Worldwide.

Contact:
Renda Hawwa,
617-871-6405
rhawwa@intelligentmdx.com


'/>"/>
SOURCE IntelligentMDx
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
2. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
3. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
4. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
7. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
8. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
9. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
10. Baxter Named to Dow Jones Sustainability Index for Tenth Consecutive Year
11. NovaVision CEO Named Presenter at the AdvaMed 2008 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):